All News

The new provisions would be the first major update to a Medicare Part D statute impacting the pharmacy industry in nearly 20 years.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

In part 2, ASCP’s senior policy expert James Lewis breaks down the MTF system and how it is impacting the thousands of pharmacies that dispense Medicare-covered drugs.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Lumateperone shows promising remission rates for major depressive disorder, offering hope for sustained relief in adults when combined with antidepressants.

Pharmacists address the hidden risks of legal substances like nitrous oxide and kratom, emphasizing the need for public education and safety measures.

Fremanezumab significantly reduces migraine days in children and adolescents, offering a vital preventive option for managing episodic migraines.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.

Focused on lowering costs and saving patients money, the plan is focused on drug prices, insurance premiums, and some of health care’s largest companies.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

Educational interventions and pharmacist engagement enhance patient safety in OTC medication use, addressing knowledge gaps and promoting responsible self-care practices.

Mavacamten shows promise in treating adolescent obstructive hypertrophic cardiomyopathy, significantly improving heart function and safety in a pivotal trial.

A group of researchers conducts 3 focus groups centered on community pharmacies in Colorado and Utah and the impact of their closures.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Addressing the lack of evidence regarding pharmacists’ roles as immunization authorities on infant respiratory syncytial virus (RSV) vaccines.

Following approval in 2023, researchers address lessons learned from the coalition- and movement-driven efforts to approve the first OTC oral contraceptive pill.

Pharmacists received surveys to quantify their usage of collaborative practice agreements among community pharmacies in Ohio.

Pharmacists play a crucial role in preventing OTC drug abuse through proactive interventions and effective warning measures, according to recent research findings.

Pharmacy staff's confidence in the Senior Safe's effectiveness was the key factor leading to the success of managing OTC medication misuse among older adults.

US adults were surveyed about their understanding of shared clinical decision-making following the HHS overhaul of childhood vaccines.

GSK announces promising phase 3 trial results for bepirovirsen, a potential treatment for chronic hepatitis B, showing significant functional cure rates.

Coping strategies significantly influence psychological health and functional capacity in COPD patients, highlighting the need for effective management.

COVID-19 vaccination significantly reduces long-term mortality risk in chronic obstructive pulmonary disease patients, highlighting its importance for respiratory health and safety.

The administration announces back-to-back approvals for oral therapies used to treat uncomplicated urogenital gonorrhea.

Susan Thomas, RN, CCO at LucyRx, explained the unique offerings from a newly introduced women’s health benefit program launched on January 1, 2026.

Although several vaccines are still being recommended, a variety of those protecting against respiratory viruses and other diseases have been narrowed on child vaccine schedules.

FDA approves denosumab biosimilars Boncresa and Oziltus, enhancing access to affordable treatments for osteoporosis and oncology-related conditions.

The company announces that the pill is now available at over 70,000 pharmacies across the country.